|
1
|
Stewart S, MacIntyre K, Capewell S and
McMurray JJ: Heart failure and the aging population: An increasing
burden in the 21st century? Heart. 89:49–53. 2003. View Article : Google Scholar
|
|
2
|
Bettari L, Fiuzat M, Felker GM and
O'Connor CM: Significance of hyponatremia in heart failure. Heart
Fail Rev. 17:17–26. 2012. View Article : Google Scholar
|
|
3
|
Dayer M and Cowie MR: Heart failure:
Diagnosis and healthcare burden. Clin Med. 4:13–18. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sinatra ST: Metabolic cardiology: The
missing link in cardiovascular disease. Altern Ther Health Med.
15:48–50. 2009.PubMed/NCBI
|
|
5
|
Herrmann G and G D: The chemical nature of
heart failure. Ann Intern Med. 12:1233–1244. 1939. View Article : Google Scholar
|
|
6
|
Neubauer S: The failing heart-an engine
out of fuel. N Engl J Med. 356:1140–1151. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
J I: ATP and the heart [M]. Kluwer
academic publishers USA; pp. 197–216. 2002
|
|
8
|
Nagoshi T, Yoshimura M, Rosano GMC,
Lopaschuk GD and Mochizuki S: Optimization of cardiac metabolism in
heart failure. Curr Pharm Des. 17:3846–3853. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kim T and Yang Q:
Peroxisome-proliferator-activated receptors regulate redox
signaling in the cardiovascular system. World J Cardiol. 5:164–174.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Planavila A, Rodriguez-Calvo R, Jové M,
Michalik L, Wahli W, Laguna JC and Vázquez-Carrera M: Peroxisome
proliferator-activated receptor beta/delta activation inhibits
hypertrophy in neonatal rat cardiomyocytes. Cardiovasc Res.
65:832–841. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Umemoto T and Fujiki Y: Ligand-dependent
nucleo-cytoplasmic shuttling of peroxisome proliferator-activated
receptors, PPAR α and PPAR γ. Genes Cells. 17:576–596. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Scott R, O'Brien R, Fulcher G, Pardy C,
D'Emden M, Tse D, Taskinen MR, Ehnholm C and Keech A; Fenofibrate
Intervention Event Lowering in Diabetes (FIELD) Study
Investigators: Effects of fenofibrate treatment on cardiovascular
disease risk in 9,795 individuals with type 2 diabetes and various
components of the metabolic syndrome: The fenofibrate intervention
and event lowering in diabetes (FIELD) study. Diabetes Care.
32:493–498. 2009. View Article : Google Scholar :
|
|
13
|
Teshima Y, Akao M, Jones SP and Marbán E:
Uncoupling protein-2 overexpression inhibits mitochondrial death
pathway in cardiomyocytes. Circ Res. 93:192–200. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Echtay KS: Mitochondrial uncoupling
proteins - what is their physiological role? Free Radic Biol Med.
43:1351–1371. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Deng S, Yang Y, Han Y, Li X, Wang X, Zhang
Z and Wang Y: UCP2 inhibits ROS-mediated apoptosis in A549 under
hypoxic conditions. PLoS One. 7:e307142012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ingwall JS: Energy metabolism in heart
failure and remodelling. Cardiovasc Res. 81:412–419. 2009.
View Article : Google Scholar :
|
|
17
|
Askoxylakis V, Thieke C, Pleger ST, Most
P, Tanner J, Lindel K, Katus HA, Debus J and Bischof M: Long-term
survival of cancer patients compared to heart failure and stroke: A
systematic review. BMC Cancer. 10(105)2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Joiner ML, Koval OM, Li J, He BJ,
Allamargot C, Gao Z, Luczak ED, Hall DD, Fink BD, Chen B, et al:
CaMKII determines mitochondrial stress responses in heart. Nature.
491:269–273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Andalib S, Shayanfar A, Khorrami A,
Maleki-Dijazi N and Garjani A: Atorvastatin reduces the myocardial
content of coenzyme Q10 in isoproterenol-induced heart failure in
rats. Drug Res (Stuttg). 64:246–250. 2014.
|
|
20
|
Heymes C, Bendall JK, Ratajczak P, Cave
AC, Samuel JL, Hasenfuss G and Shah AM: Increased myocardial NADPH
oxidase activity in human heart failure. J Am Coll Cardiol.
41:2164–2171. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Burkart EM, Sambandam N, Han X, Gross RW,
Courtois M, Gierasch CM, Shoghi K, Welch MJ and Kelly DP: Nuclear
receptors PPARbeta/delta and PPARalpha direct distinct metabolic
regulatory programs in the mouse heart. J Clin Invest.
117:3930–3939. 2007.PubMed/NCBI
|
|
22
|
Wolins NE, Quaynor BK, Skinner JR, Tzekov
A, Croce MA, Gropler MC, Varma V, Yao-Borengasser A, Rasouli N,
Kern PA, et al: OXPAT/PAT-1 is a PPAR-induced lipid droplet protein
that promotes fatty acid utilization. Diabetes. 55:3418–3428. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sack MN, Rader TA, Park S, Bastin J,
McCune SA and Kelly DP: Fatty acid oxidation enzyme gene expression
is downregulated in the failing heart. Circulation. 94:2837–2842.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Garnier A, Fortin D, Deloménie C, Momken
I, Veksler V and Ventura-Clapier R: Depressed mitochondrial
transcription factors and oxidative capacity in rat failing cardiac
and skeletal muscles. J Physiol. 551:491–501. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murray AJ, Anderson RE, Watson GC, Radda
GK and Clarke K: Uncoupling proteins in human heart. Lancet.
364:1786–1788. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Noma T, Nishiyama A, Mizushige K, Murakami
K, Tsuji T, Kohno M, Rahman M, Fukui T, Abe Y and Kimura S:
Possible role of uncoupling protein in regulation of myocardial
energy metabolism in aortic regurgitation model rats. FASEB J.
15:1206–1208. 2001.PubMed/NCBI
|
|
27
|
Young ME, Patil S, Ying J, Depre C, Ahuja
HS, Shipley GL, Stepkowski SM, Davies PJ and Taegtmeyer H:
Uncoupling protein 3 transcription is regulated by peroxisome
proliferator-activated receptor (alpha) in the adult rodent heart.
FASEB J. 15:833–845. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Li P, Yin K, Luo SK and Cheng XS: Effect
of uncoupling protein-2 on angiotensin II induced reactive oxygen
species generation in mitochondria. Chinese Journal of
Hypertension. 18:940–945. 2010.In Chinese.
|
|
29
|
Luo SK, Li P and Cheng XS: Establishment
of model of isoprenaline-induced chronic heart failure in rats.
Chongqing Yixue. 41:352–354. 2012.
|
